Cargando…

High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy

High levels of adherence to antiretroviral therapy (ART) are necessary for achieving and maintaining optimal virological suppression, as suboptimal adherence leads to therapy failure and disease progression. It is well known that adherence to ART predicts therapy response, but it is unclear whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasternak, Alexander O., de Bruin, Marijn, Bakker, Margreet, Berkhout, Ben, Prins, Jan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607457/ https://www.ncbi.nlm.nih.gov/pubmed/26468956 http://dx.doi.org/10.1371/journal.pone.0140791

Ejemplares similares

Modest deviations from optimal adherence to antiretroviral therapy promote residual HIV-1 replication in the absence of virological rebound in plasma
por: Pasternak, Alexander O, et al.
Publicado: (2011)

Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome
por: Pasternak, Alexander O., et al.
Publicado: (2009)

Has the Rate of CD4 Cell Count Decline before Initiation of Antiretroviral Therapy Changed over the Course of the Dutch HIV Epidemic among MSM?
por: Gras, Luuk, et al.
Publicado: (2013)

Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy
por: Pasternak, Alexander O, et al.
Publicado: (2021)

Factors associated with suboptimal adherence to antiretroviral therapy in Asia
por: Jiamsakul, Awachana, et al.
Publicado: (2014)

Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy
por: Scherpenisse, Mirte, et al.
Publicado: (2021)

Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2017)

CD32(+)CD4(+) T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency
por: Darcis, Gilles, et al.
Publicado: (2020)

Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy
por: van Zoest, Rosan A, et al.
Publicado: (2017)

Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia
por: Konstantopoulos, Christina, et al.
Publicado: (2015)

Factors influencing antiretroviral treatment suboptimal adherence among perinatally HIV-infected adolescents in Thailand
por: Xu, Luyi, et al.
Publicado: (2017)

Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression
por: Siefried, Krista J., et al.
Publicado: (2017)

Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe
por: Akinwunmi, Babatunde, et al.
Publicado: (2021)

Pharmacy Refill Adherence Compared with CD4 Count Changes for Monitoring HIV-Infected Adults on Antiretroviral Therapy
por: Bisson, Gregory P, et al.
Publicado: (2008)

Systematic adaptation of the adherence improving self‐management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach
por: Janssen, Anna M., et al.
Publicado: (2022)

Predictors of Suboptimal Adherence Among Children on Antiretroviral Therapy in Southern Ethiopia: A Multicenter Retrospective Follow-Up Study
por: Guyo, Tamirat Gezahegn, et al.
Publicado: (2023)

Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective
por: Lyimo, Ramsey A, et al.
Publicado: (2012)

Level of suboptimal adherence to first line antiretroviral treatment & its determinants among HIV positive people in India
por: Joshi, Beena, et al.
Publicado: (2014)

Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System
por: Lyimo, Ramsey A, et al.
Publicado: (2011)

Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study
por: Ndiaye, Maimouna, et al.
Publicado: (2013)

HIV-1 dual infection is associated with faster CD4+T cell decline in a cohort of men with primary HIV infection
por: Cornelissen, Marion, et al.
Publicado: (2011)

Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013
por: van der Kuyl, Antoinette C, et al.
Publicado: (2013)

Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand()
por: Han, Win Min, et al.
Publicado: (2020)

The Use of Pill Counts as a Facilitator of Adherence with Antiretroviral Therapy in Resource Limited Settings
por: Achieng, Loice, et al.
Publicado: (2013)

Empiric Deworming and CD4 Count Recovery in HIV-Infected Ugandans Initiating Antiretroviral Therapy
por: Lankowski, Alexander J., et al.
Publicado: (2014)

Long-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy
por: Luz, Paula M., et al.
Publicado: (2014)

Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
por: Balak, Dashika A., et al.
Publicado: (2014)

Predicting Post-treatment HIV Remission: Does Size of the Viral Reservoir Matter?
por: Pasternak, Alexander O., et al.
Publicado: (2021)

The impact of an integrated health-system specialty pharmacy on HIV antiretroviral therapy adherence, viral suppression and CD4 count in an outpatient ID clinic
por: Barnes, Elizabeth, et al.
Publicado: (2019)

Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever
por: Kevat, Priya M, et al.
Publicado: (2020)

Predictors of Current CD4+ T-Cell Count Among Women of Reproductive Age on Antiretroviral Therapy in Public Hospitals, Southwest Ethiopia
por: Belay, Alemayehu Sayih, et al.
Publicado: (2021)

Did Universal Access to ARVT in Mexico Impact Suboptimal Antiretroviral Prescriptions?
por: Caro-Vega, Yanink, et al.
Publicado: (2013)

Determinants of suboptimal CD4(+) T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV‐1 infection
por: Handoko, Ryan, et al.
Publicado: (2020)

Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI)
por: Do, Hoa M, et al.
Publicado: (2013)

Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV
por: Kay, Alexander W., et al.
Publicado: (2020)

Comparing Absolute Lymphocyte Count to Total Lymphocyte Count, as a CD4 T Cell Surrogate, to Initiate Antiretroviral Therapy
por: Sreenivasan, Srirangaraj, et al.
Publicado: (2011)

Is total lymphocyte count a predictor for CD4 cell count in initiation antiretroviral therapy in HIV-infected patients?
por: Abdollahi, Alireza, et al.
Publicado: (2014)

Predicting Malawian Women’s Intention to Adhere to Antiretroviral Therapy
por: McKinney, Ogbochi, et al.
Publicado: (2015)

The Effect of an Integrated Health System Specialty Pharmacy on HIV Antiretroviral Therapy Adherence, Viral Suppression, and CD4 Count in an Outpatient Infectious Disease Clinic
por: Barnes, Elizabeth, et al.
Publicado: (2020)

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
por: Trickey, Adam, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fs39m2crdhbed5dliumb33sk2n